Chris Boshoff
CSO @ Pfizer
New York, United States
Chris Boshoff is a post-ipo equity investor at Pfizer in New York focused on Biopharma and Biotechnology. Chris Boshoff is the Chief Scientific Officer of Pfizer. He attended The Institute of Cancer Research.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Chris Boshoff invests in
Stages Chris Boshoff invests in
Countries Chris Boshoff invests in
Investment Focus
Industry
- Biopharma 1 (100%)
- Biotechnology 1 (100%)
- Pharmaceutical 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Zentalis Pharmaceuticals
|
Zentalis Pharmaceuticals Inc is a clinical-stage biopharmaceutical business dedicated to finding and developing small molecule medicines that target cancer's underlying biological pathways. It employs an integrated discovery engine to find targets and produce small molecule new chemical entities, or NCEs, with features that it believes couldresult in potentially distinct product profiles. Its pipeline includes two lead product candidates: ZN-c5, which is being developed for the treatment of advanced estrogen receptor-positive, human epidermal growth factor receptor 2-negative, or ER+/HER2-, advanced or metastatic breast cancer, and ZN-c3, which is being developed for the treatment of advanced solid tumors as monotherapy and ovarian cancer. | $25M / Post-IPO Equity / Apr 27, 2022 |
About Pfizer
Pfizer provides access to safe and effective and affordable medicines and health care services. They have a portfolio of products and medicines that support wellness and prevention, as well as treatment and cures for diseases across a broad range of therapeutic areas; and they have an industry-leading pipeline of promising new products that havethe potential to challenge some of the most feared diseases of their time, like Alzheimer's disease and cancer.
Pfizer Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alessandra Leone
Global CMC Sr. Manager
|
|||
|
Angela L Coral
Senior Manager, Partnerships & Impact Reporting, Global Health & Social Impact
|
|||
Barbara Dalton
Senior Managing Partner, Pfizer Ventures; VP, Worldwide Business Development
|
|||
|
Chris Boshoff
CSO
|
|||
Chris O’Donnell
Partner, Pfizer Ventures & Executive Director, Emerging Sciences & Innovation
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Chris Boshoff invest in?
Chris Boshoff invests primarily in Biopharma, Biotechnology and Pharmaceutical startups, most often at Post-IPO Equity stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Chris Boshoff last invest?
The most recent investment recorded for Chris Boshoff closed in Apr 2022. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
